Adents, Microsoft Partner on Track & Trace Cloud Platform
News Nov 04, 2016
Indentations and Microsoft have decided to combine their skills to build and market a cloud platform called indentations Prodigi. Indentations Prodigi is the only level traceability solution 4 can centrally manage regulatory requirements of the pharmaceutical industry and to give laboratories and converters the ability to take advantage of the mass of information from the serialization process and Track & Trace.
Beyond regulatory compliance, ADENTS Prodigi opens new horizons in terms of:
• Identification and traceability
• Fight against counterfeiting
• Monitoring of the productivity of production sites
• Customer experience and personalized communication
• Data visualization and analysis in real time
Expertise of ADENTS, identification and traceability are supported by a global trend to regulation. Over 80% of world production of medicines will be forced to the identification unit 2019. This new process offers extraordinary opportunities in terms of visibility on the lives of pharmaceuticals and requires a major challenge in terms of data management.
Indentations Prodigi relies on Microsoft Azure advanced technology and enables pharmaceutical companies to generate, exchange and safely control the vast amount of data generated by the identification unit. Data Analytics tools (including MS Power BI) and Machine Learning are also available on the platform ADENTS Prodigi, providing powerful analysis capabilities of these new information fields.
Indentations Prodigi is developed and supported by a joint team indentations and Microsoft, and is intended to host third-party business applications using the data of the platform. Indentations Prodigi is the solution to meet the new regulations but above all, to finally exploit new data and better manage activity.
"Our alliance with the leader in enterprise BI solutions will change the situation on the world market of the unit identification. Indeed, it empowers industrial companies to create and operate the digital profile of their products, with a mine information for all stakeholders in the product life cycle, " explains Christophe Devins, CEO and founder of ADENTS.
Concept Life Sciences appoints New Group Programme Manager and US Head of SalesNews
Key leadership appointments support integration of the Group and expansion in the US market.READ MORE
Alzheimer’s Drug Discovery Foundation Announces $1.8M in New FundingNews
The Alzheimer’s Drug Discovery Foundation (ADDF) announces nearly $1.8 million in new funding, which reflects a commitment to advancing drugs in or near human clinical trials. All five funded programs are potential treatments for Alzheimer’s disease and other forms of dementia.READ MORE
New Research Hub to Tackle Global Vaccination ChallengesNews
The University of Bristol will contribute to a new research hub to increase global immunisation coverage and improve response to viral outbreaks through the rapid and cost-effective deployment of vaccines.READ MORE